Kyprolis

Do you want to link to this Amgen Site and leave Amgen.co.kr?

YOU ARE NOW LEAVING AMGEN KOREA'S WEB SITE. Amgen Korea takes takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

KYPROLIS® Inj. 60mg, 30mg

  • Product Name (Korean) 키프롤리스®주 60mg, 키프롤리스®주 30mg
  • Product Name (English) Kyprolis®  Inj. 60mg, Kyprolis®  Inj. 30mg
  • Active Ingredient (Korean) 카르필조밉
  • Active Ingredient (English) carfilzomib
  • API content 60 mg/vial, 30 mg/vial
  • Excipients Betadex sulfobutyl ether sodium (SBECD), Anhydrous citric acid, Sodium hydroxide
  • Treatment Treatment of multiple myeloma.
  • Indications For the treatment of patients with multiple myeloma who have received at least one prior therapy in combination with:
    • Lenalidomide and dexamethasone, or
    • Dexamethasone, or
    • Daratumumab and dexamethasone.
  • KYPROLIS® Medication Guide